These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Aggrecan degradation in osteoarthritis and rheumatoid arthritis. Lark MW, Bayne EK, Lohmander LS. Acta Orthop Scand Suppl; 1995 Oct 01; 266():92-7. PubMed ID: 8553869 [No Abstract] [Full Text] [Related]
11. Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo. Sandy JD, Verscharen C. Biochem J; 2001 Sep 15; 358(Pt 3):615-26. PubMed ID: 11535123 [Abstract] [Full Text] [Related]
12. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Manicourt DH, Poilvache P, Van Egeren A, Devogelaer JP, Lenz ME, Thonar EJ. Arthritis Rheum; 2000 Feb 15; 43(2):281-8. PubMed ID: 10693867 [Abstract] [Full Text] [Related]
14. Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid. Céleste C, Ionescu M, Robin Poole A, Laverty S. J Orthop Res; 2005 May 15; 23(3):602-10. PubMed ID: 15885481 [Abstract] [Full Text] [Related]
18. Contents and distributions of the proteoglycans decorin and biglycan in normal and osteoarthritic human articular cartilage. Poole AR, Rosenberg LC, Reiner A, Ionescu M, Bogoch E, Roughley PJ. J Orthop Res; 1996 Sep 15; 14(5):681-9. PubMed ID: 8893759 [Abstract] [Full Text] [Related]